Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure Outcomes

Gala Beykin, Laurel Stell, Muhammad Sohail Halim, Mariana Nuñez, Lilia Popova, Bac Tien Nguyen, Sylvia L. Groth, Amy Baker Dennis, Zhongqiu Li, Melissa Atkins, Tom Khavari, Sophia Y. Wang, Robert T. Chang, Ann Fisher, Yasir J. Sepah, Jeffrey L. Goldberg